Hiroyuki Yasojima

Distinct gene expression profiles between primary breast cancers and brain metastases from pair-matched samples

Takayuki Iwamoto, Naoki Niikura, Rin Ogiya et al. · Scientific Reports · 2019 · 216 citations · Full text

Medicine, Cancer Biology, Oncology +17

Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis

Naoki Niikura, Naoki Hayashi, Norikazu Masuda et al. · Breast Cancer Research and Treatment · 2014 · 199 citations

Medicine, Oncology, Surgery +14

LBA21 KEYNOTE-756: Phase III study of neoadjuvant pembrolizumab (pembro) or placebo (pbo) + chemotherapy (chemo), followed by adjuvant pembro or pbo + endocrine therapy (ET) for early-stage high-risk ER+/HER2– breast cancer

Fátima Cardoso, Heather L. McArthur, Peter Schmid et al. · Annals of Oncology · 2023 · 134 citations · Full text

Medicine, Oncology, Pharmacology +17

Pembrolizumab and chemotherapy in high-risk, early-stage, ER+/HER2− breast cancer: a randomized phase 3 trial

Fátima Cardoso, Joyce O’Shaughnessy, Zhenzhen Liu et al. · Nature Medicine · 2025 · 114 citations · Full text

Medicine, Oncology, Pharmacology +17

Comparison of immune microenvironments between primary tumors and brain metastases in patients with breast cancer

Rin Ogiya, Naoki Niikura, Nobue Kumaki et al. · Oncotarget · 2017 · 92 citations · Full text

Medicine, Immunology, Oncology +17